MICM
WX

Matthews International Capital Management’s WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS WX Stock Holding History

Matthews International Capital Management’s Portfolio WX Stock Details WX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-2,694,589
Closed -$116M – 39
2015
Q3 		$116M Sell
2,694,589
-54,600
-2% -$2.3M 5.17% 8
2015
Q2 		$116M Sell
2,749,189
-32,700
-1% -$1.38M 4.03% 11
2015
Q1 		$108M Buy
2,781,889
+1,612,203
+138% +$62.1M 3.77% 11
2014
Q4 		$39.4M Buy
1,169,686
+1,016,486
+664% +$35.9M 1.64% 11
2014
Q3 		$5.37M Buy
153,200
+4,500
+3% +$154K 0.25% 24
2014
Q2 		$4.89M Buy
148,700
+500
+0.3% +$17.1K 0.27% 21
2014
Q1 		$5.46M Sell
148,200
-7,800
-5% -$286K 0.3% 20
2013
Q4 		$5.99M Buy
156,000
+1,700
+1% +$53.7K 0.3% 17
2013
Q3 		$4.23M Buy
154,300
+7,400
+5% +$175K 0.22% 19
2013
Q2 		$3.08M Buy
+146,900
New +$2.87M 0.17% 19

Other funds holding WX

Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
CCS
Crosspoint Capital Strategies Orinda, California $50.4M AUM 15.37% 1-Year Est. Return

Matthews International Capital Management's WX Position: Q4 2015 in Review

Matthews International Capital Management sold out of WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS (WX) in Q4 2015, closing a stake of 2,694,589 shares — an estimated $116M sold.

Matthews International Capital Management first reported a position in WX in Q2 2013 and held it in 10 quarters. The position peaked at $116M in Q3 2015. 2 funds tracked by Wall St. Rank hold WX as of Q4 2015.

  • Matthews International Capital Management reported no remaining WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS position as of Q4 2015 after selling out during the quarter.
  • Matthews International Capital Management sold 2,694,589 WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS shares in Q4 2015, an estimated $116M.
  • Matthews International Capital Management first reported a position in WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS in Q2 2013 and held it in 10 quarters.
  • Matthews International Capital Management's WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS position peaked at $116M in Q3 2015.
  • 2 funds tracked by Wall St. Rank held WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS as of Q4 2015.

Based on Matthews International Capital Management's 13F filing for Q4 2015, filed 11 Feb 2016.